February 17, 2022
The U.S. Department of Health and Human Services disregarded federal law when it sent AstraZeneca a violation letter accusing it of going against a nationwide program mandating discount drug prices for targeted groups, a Delaware federal judge determined.
October 18, 2021
A federal judge in Delaware said Monday he was not persuaded that AstraZeneca Pharmaceuticals LP urgently needs a quick ruling on its bid to scuttle federal enforcement actions accusing it of violating a nationwide program mandating discount drug prices for targeted groups.
June 18, 2021
Following a court defeat, the U.S. Department of Health and Human Services late Friday told federal courts that it has withdrawn its December finding that drug manufacturers can't limit the number of pharmacies eligible to fill government-set, capped-cost prescriptions for eligible organizations.
June 16, 2021
A U.S. District Court judge in Delaware refused to dismiss on Wednesday an AstraZeneca Pharmaceuticals LP challenge to a Department of Health and Human Services finding that drug manufacturers can't limit the number of pharmacies eligible to fill government-set, capped-cost prescriptions for eligible organizations.
January 13, 2021
AstraZeneca, Eli Lilly and Sanofi-Aventis have launched a series of lawsuits challenging the U.S. Department of Health and Human Services' view that drugmakers have to give discounts to pharmacies contracting with hospitals that participate in a program serving low-income areas.